Psoriasis can involve any area of the skin. The most common areas are those that are prone to significant trauma from rubbing or scratching. These areas include the elbows, knees and scalp. However, ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...

Psoriatic arthritis (PsA) affects roughly 30% of patients with psoriasis, yet no 2 cases look alike, says Philip Mease, MD, director of rheumatology and research, Providence Swedish Medical Center, ...

– Late-breaking oral presentation to highlight 52-week data of ESK-001 in a Phase 2 open-label extension (OLE) study in adults with moderate-to-severe plaque psoriasis – – Additional Phase 2 e-poster ...